Denali Therapeutics Inc.
MODULATORS OF EUKARYOTIC INITIATION FACTOR 2
Last updated:
Abstract:
The present disclosure relates generally to eukaryotic initiation factor 2B modulators of formula A, or a pharmaceutically acceptable salt, stereoisomer, or mixture of stereoisomers thereof and methods of making and using thereof. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
22 Mar 2019
Issue date:
6 May 2021